Axon Seminar In Vitro Diagnostics Wednesday 12 September 2012

Bringing an in vitro diagnostic product to the market is challenging and complex. Rules at the EU and national level are constantly changing, while regulatory policy is developing to get to grips with new products. A robust and scientifically supported regulatory and legal strategy is therefore key to successful market access.

Speakers and their presentations:

Sabine Ohse, Head Medical Devices Certification at BSI Group Regulatory strategy for in vitro diagnostics in the EU

Henk Vietor, CEO at Skyline Diagnostics Company experience with regulatory issues and how to deal with them

Erik Vollebregt, Partner at Axon Lawyers IVD Capita Exotica

Carine van den Brink, Partner at Axon Lawyers Promotion and sale of IVDs in EU


Navigate through our knowledgebase

Related articles

Article

Seminar MDR & IVDR Implementation Countdown – slides

191002-Erik Vollebregt-MDR Countdown 191002-Paul van Geffen- Last elements before implementation 191002-Sue Spencer – IVDR Executive summary 191002-Ronald Boumans- Latest on Eudamed

Article

Trends from Silicon Valley for meat alternatives

What does the future of our meat look like? This topic was the subject of the Annual Conference of the Good Food Institute (GFI), which took place in San Francisco last month. GFI is an American non-profit organization that works with entrepreneurs, scientists and investors to make groundbreaking good food a reality. GFI focuses on […]

Article

New sort of applicable economic operators regulation: the Market Surveillance Regulation

Attentive attendees of my presentations will have remarked in my presentations about economic operators that essential parts of the general Goods Package were being amended and that this may affect companies in…

Read more